ResearcherSanford ResearchNo recent work listed
Neeraj Chauhan
Matched on ORCID iD 0000-0001-6215-7132; OpenAlex author ID A5049530504. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2013: 1 paper · 2014: 1 paper · 2015: 2 papers · 2016: none · 2017: none · 2018: none · 2019: 3 papers · 2020: 1 paper
Papers 8
- Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells. Co-author DOI 10.1021/acsomega.9b03382↗
- Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. Co-author DOI 10.1016/j.nano.2019.102027↗
- Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. Co-author DOI 10.1186/s13046-018-1009-7↗
- Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer). Co-author DOI 10.3390/cells9010103↗
- Nanoparticle formulation of ormeloxifene for pancreatic cancer. First author DOI 10.1016/j.biomaterials.2015.02.082↗
- Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. Co-author DOI 10.1158/0008-5472.can-14-2397↗
- MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Co-author DOI 10.18632/oncotarget.2281↗
- Novel curcumin-loaded magnetic nanoparticles for pancreatic cancer treatment. Co-author DOI 10.1158/1535-7163.mct-12-1227↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Meena Jaggi · 8 shared papers, 2013–2020 · strength 0.55
- Paper Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells. DOI 10.1021/acsomega.9b03382↗
- Paper Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pa… DOI 10.3390/cells9010103↗
- Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
- Murali Mohan Yallapu · 8 shared papers, 2013–2020 · strength 0.55
- Paper Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells. DOI 10.1021/acsomega.9b03382↗
- Paper Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pa… DOI 10.3390/cells9010103↗
- Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
- Subhash C. Chauhan · 8 shared papers, 2013–2020 · strength 0.55
- Paper Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells. DOI 10.1021/acsomega.9b03382↗
- Paper Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pa… DOI 10.3390/cells9010103↗
- Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
- Sheema Khan · 6 shared papers, 2013–2019 · strength 0.33
- Paper Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pa… DOI 10.3390/cells9010103↗
- Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
- Paper Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. DOI 10.1158/0008-5472.can-14-2397↗
- Sonam Kumari · 3 shared papers, 2019 · strength 0.26
- Paper Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pa… DOI 10.3390/cells9010103↗
- Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
- Paper Therapeutic efficacy of a novel βIII/βIV-tubulin inhibitor (VERU-111) in pancreatic cancer. DOI 10.1186/s13046-018-1009-7↗
- Mohammed Sikander · 3 shared papers, 2014–2019 · strength 0.21
- Paper Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pa… DOI 10.3390/cells9010103↗
- Paper Next-generation paclitaxel-nanoparticle formulation for pancreatic cancer treatment. DOI 10.1016/j.nano.2019.102027↗
- Paper MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. DOI 10.18632/oncotarget.2281↗
- Bilal Bin Hafeez · 2 shared papers, 2019 · strength 0.17
- Vivek Kumar Kashyap · 2 shared papers, 2019 · strength 0.17
- Saini Setua · 2 shared papers, 2019 · strength 0.17
- Fathi T. Halaweish · 2 shared papers, 2015–2019 · strength 0.13
- Stephen W. Behrman · 3 shared papers, 2014–2015 · strength 0.12
- Paper Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer. DOI 10.1158/0008-5472.can-14-2397↗
- Paper Nanoparticle formulation of ormeloxifene for pancreatic cancer. DOI 10.1016/j.biomaterials.2015.02.082↗
- Paper MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. DOI 10.18632/oncotarget.2281↗
- Andrew E. Massey · 1 shared paper, 2019 · strength 0.08
- Advait B. Shetty · 1 shared paper, 2019 · strength 0.08
- Wěi Li · 1 shared paper, 2019 · strength 0.08
- Deepak Kumar · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.